Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain

<p>Abstract</p> <p>Neuropathic pain is a debilitating clinical condition with few efficacious treatments, warranting development of novel therapeutics. We hypothesized that dysregulated translation regulation pathways may underlie neuropathic pain. Peripheral nerve injury induced r...

Full description

Bibliographic Details
Main Authors:	Peebles Katherine A, Johnson Jessica, Khoutorsky Arkady, Lark Arianna, Yan Jin, Sanoja Raul, Tillu Dipti V, Asiedu Marina N, Melemedjian Ohannes K, Lepow Talya, Sonenberg Nahum, Dussor Gregory, Price Theodore J
Format:	Article
Language:	English
Published:	SAGE Publishing 2011-09-01
Series:	Molecular Pain
Online Access:	http://www.molecularpain.com/content/7/1/70

Internet

http://www.molecularpain.com/content/7/1/70

Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain

Internet

Similar Items